New Peer-Reviewed Preclinical Study Demonstrates Regenerative Potential of Spinogenix's Tazbentetol for Treating Diabetic Retinal Neuropathy

Data ReadoutpositiveTazbentetolPositive

AI Analysis

Summary

Spinogenix published peer-reviewed preclinical data in Experimental Eye Research showing tazbentetol preserved retinal synapses and reduced neurodegenerative changes in a diabetic retinal neuropathy model.

Outcome Details

Preclinical study published in Experimental Eye Research demonstrated tazbentetol preserved retinal synapses and reduced neurodegenerative changes in a preclinical model

Importance:3/10

Sentiment:

0.60

preclinicalophthalmologyneuropathypeer-reviewed publicationregenerative medicine

Related Companies

$TRAX

Read the original article

Published by PR Newswire Biotech on October 6, 2026 12:30 PM

Read Original